BioIntelliSense has entered into a strategic partnership with the American College of Cardiology (ACC). The arrangement specifically concerns BioIntelliSense’s BioButton and BioSticker wearables, which will […]

Royal Philips and BioIntelliSense have won a $2.8 million contract to trial the use of biometric wearable devices for the detection of pre-symptomatic COVID-19 cases. […]

Amsterdam-based healthcare technology company BioIntelliSense has announced a new partnership that will see healthcare technology company Royal Philips integrate its BioSticker biometric monitoring solution with […]

BioIntelliSense is continuing to build its Data-as-a-Service portfolio with the release of a new 5G BioHub. The BioHub arrives shortly after BioIntelliSense received FDA clearance […]